As of 2026-09-14, the Intrinsic Value of Preveceutical Medical Inc (PREV.CN) is -0.12 CAD. This PREV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Preveceutical Medical Inc is -676.87%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Preveceutical Medical Inc (PREV.CN) is overvalued by 676.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.12 - -0.12 | -0.12 | -676.87% |
| DDM - Stable | (0.05) - (0.32) | (0.19) | -1035.9% |
| DDM - Multi | (0.02) - (0.12) | (0.04) | -303.4% |
| Market Cap (mil) | 8.97 |
| Beta | -1.90 |
| Outstanding shares (mil) | 448.64 |
| Enterprise Value (mil) | 13.47 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.39% |
| Cost of Debt | 5.00% |
| WACC | 7.93% |